SEC Form 3
FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 07/27/2021 | 3. Issuer Name and Ticker or Trading Symbol MeridianLink, Inc. [ MLNK ] | |||||||||||||
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock, par value $0.001 per share | 40,463,246(1) | I | See footnote(2) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
Explanation of Responses: |
1. Consists of 16,790,225 shares held directly by Thoma Bravo Discover Fund, L.P. ("TB Discover"), 3,441,398 shares held directly by Thoma Bravo Discover Fund A, L.P. ("TB Discover A"), 13,986,203 shares held directly by Thoma Bravo Discover Fund II, L.P. ("TB Discover II"), 5,936,909 shares held directly by Thoma Bravo Discover Fund II-A, L.P. ("TB Discover II-A") and 308,511 shares held directly by Thoma Bravo Discover Executive Fund II, L.P. ("TB Discover Exec II"). |
2. Thoma Bravo Discover Partners , L.P. ("TB Discover Partners") is the general partner of each of TB Discover and TB Discover A. Thoma Bravo Discover Partners II, L.P. ("TB Discover Partners II") is the general partner of each of TB Discover II, TB Discover II-A and TB Discover Exec II. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of each of TB Discover Partners and TB Discover Partners II. By virtue of the relationships described in this footnote, TB UGP, may be deemed to exercise voting and dispositive power with respect to the shares held directly by TB Discover, TB Discover A, TB Discover II, TB Discover II-A and TB Discover Exec II. TB UGP, disclaims beneficial ownership of the shares owned by TB Discover, TB Discover A, TB Discover II, TB Discover II-A and TB Discover Exec II except to the extent of its pecuniary interest therein, if any. |
Remarks: |
/s/ Arthur J. Rohde, Authorized Signatory Thoma Bravo UGP, LLC | 07/27/2021 | |
/s/ Arthur J. Rohde, Authorized Signatory of Thoma Bravo, UGP, the ultimate GP of Thoma Bravo Discover Fund, L.P. | 07/27/2021 | |
/s/ Arthur J. Rohde, Authorized Signatory of Thoma Bravo, UGP, the ultimate GP of Thoma Bravo Discover Fund A, L.P. | 07/27/2021 | |
/s/ Arthur J. Rohde, Authorized Signatory of Thoma Bravo, UGP, the ultimate GP of Thoma Bravo Discover Fund II, L.P. | 07/27/2021 | |
/s/ Arthur J. Rohde, Authorized Signatory of Thoma Bravo, UGP, the ultimate GP of Thoma Bravo Discover Fund II-A, L.P. | 07/27/2021 | |
/s/ Arthur J. Rohde, Authorized Signatory of Thoma Bravo, UGP, the ultimate GP of Thoma Bravo Discover Executive Fund II, L.P. | 07/27/2021 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |